MoneyWorks4Me

Hikal - Quaterly Results

01 Aug 2024 Evaluate
With no major difference for the quarter endedJune 2024 , the total revenue stood at Rs. 4068.00  millions.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 52.00  millions as against Rs. 69.00 millions reported during the corresponding quarter ended.Operating profit for the quarter ended June 2024 rose to 586.00 millions as compared to 512.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4068.00 3880.00 4.85 4068.00 3880.00 4.85 17846.00 20230.30 -11.79
Other Income 5.00 9.00 -44.44 5.00 9.00 -44.44 24.50 54.10 -54.71
PBIDT 586.00 512.00 14.45 586.00 512.00 14.45 2693.90 2624.70 2.64
Interest 198.00 138.00 43.48 198.00 138.00 43.48 563.70 481.00 17.19
PBDT 388.00 374.00 3.74 388.00 374.00 3.74 2130.20 2143.70 -0.63
Depreciation 318.00 277.00 14.80 318.00 277.00 14.80 1176.10 1090.10 7.89
PBT 70.00 97.00 -27.84 70.00 97.00 -27.84 954.10 1053.60 -9.44
TAX 18.00 28.00 -35.71 18.00 28.00 -35.71 259.00 269.80 -4.00
Deferred Tax 3.00 1.00 200.00 3.00 1.00 200.00 -24.70 -35.00 -29.43
PAT 52.00 69.00 -24.64 52.00 69.00 -24.64 695.10 783.80 -11.32
Equity 247.00 246.60 0.16 247.00 246.60 0.16 246.60 246.60 0.00
PBIDTM(%) 14.41 13.20 9.16 14.41 13.20 9.16 15.10 12.97 16.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..